Background
==========

Soft-tissue sarcomas (STS) form a large and heterogeneous group of mesenchymal extraskeletal malignancies that account for \< 1% of all malignant tumors in the general population \[[@B1]\]. ST can develop virtually anywhere in the body, however, most tumors originate in an extremity (59%), the trunk (19%), the retroperitoneum (15%), or the head and neck (9%) \[[@B2]\]. Despite the variety of histologic subtypes, soft tissue sarcomas are grouped together at the clinical level because of parameters such as location, growth pattern and likelihood of recurrence, patient age, metastases, therapy, and prognosis \[[@B1]\].

Treatment of extremity STS has seen an evolution from radical surgery with liberal use of amputation to a limb-sparing approach \[[@B3]\]. The major therapeutic goals are long-term survival, avoidance of local recurrence, maximizing function and minimizing morbidity. Landmark trials conducted in the 1970s and 1980s at the National Cancer Institute showed equivalent survival outcomes between limb amputation and limb sparing surgery combined with radiotherapy (RT) \[[@B4],[@B5]\]. However, despite apparently complete resections, one-third of patients with extremity STS suffer recurrence, typically within two years \[[@B6],[@B7]\]. Several risk factors associated with recurrence have repeatedly been reported in the literature, including histologic subtype; tumor location, size, depth, and grade; and surgical margin \[[@B8]-[@B10]\].

Managing STS in a developing country is a challenge. Limited financial resources do not allow patients to come early to tertiary care centers. Presenting late, these extremity STS are prone to recurrence despite apparently complete resection. Against this background we hypothesized that patients from this part of the world would have a poorer prognosis with higher recurrence rates and lower overall survival. Given the reported geographic variance between prognostic factors for other cancers, we also hypothesized that similar variance would exist in STS as well and a different set of prognostic factors would influence recurrence rates and survival in our population. The goal of this investigation was to explore the impact of clinic-pathological factors on local recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), and overall survival (OS) in patients with primary localized extremity STS undergoing surgical resection and compare it with figures quoted from the developed world since no similar studies have been presented from our country.

Methods
=======

This study was a retrospective cohort analysis of consecutive patients with STS of an extremity, who did not have synchronous metastasis or local recurrence (LR) on presentation, and who received primary surgery at the Aga Khan University Hospital from January 1994 through December 2008.

The demographic data and clinical characteristics of the study population were acquired from clinical chart review, tumor registry information, physicians' records, patients' correspondence, and telephone interviews.

All tumors were reviewed by experienced pathologists at our institution. Tumors were diagnosed and graded according to the FNCLCC (French Federation Nationale des Centres de Lutte Contre le Cancer) system \[[@B11]\]. For analyses, FNCLCC grade two and three tumors were defined as high grade tumors, and grade one as low grade \[[@B12]\]. Tumor size was classified as \< 5 cm or ≥ 5 cm. Tumors were characterized as superficial or deep according to the involvement of the investing fascia \[[@B13]\].

Margins were evaluated intra-operatively by a dedicated pathologist. Margins were inked and separately sampled. The closest margin was microscopically categorized as positive (tumor within 1 mm of the inked surface) or negative (absence of tumor within 1 mm of the inked surface) and was further classified into the following categories: \< 4 mm, 5 to 9 mm, 10 to 19 mm and ≥ 20 mm. Radiotherapy was recommended for patients with tumors exhibiting high risk factors for recurrence: anyone or combination of factors including size \> 5 cm, high grade, deep tumors and inadequate surgical margins.

Approval for this study was sought from our hospital's Ethical review Committee.

Statistical analysis
--------------------

Patients were evaluated from the time of their histological diagnosis up to their latest uneventful follow-up visit or disease progression, recurrence, metastasis or death. Patients who did not experience the event of interest or death over the course of the study were censored at their last follow-up. LRFS rates were calculated from diagnosis to local progression or relapse at the same or adjacent tumor site. All other tumor recurrences were classified as distant metastases and metastases-free survival (MFS) rates were calculated from diagnosis to the onset of distant metastases.

To explore the prognostic factors for the survival of patients, a univariate analysis with the Kaplan--Meier method was estimated for survival curves, and the log-rank statistical test with two-sided test was applied to test the significance between survival curves and every potential risk factor. Variables were included on the basis of previous reports from the literature. A stepwise multivariate Cox regression survival model was applied to evaluate the potential prognostic factors identified in the univariate analysis. The limits for the selection were *P* = 0.05 for entry and *P* = 0.10 for removal by the likelihood ratio test. Data were analyzed using SPSS software (version 19, SPSS, Chicago, IL, USA).

Results
=======

Clinico-pathological characteristics of the patients
----------------------------------------------------

During the study period, a total of 84 consecutive adult STS patients received treatment at our institute. The main features of the study population and patient management are summarized in Table [1](#T1){ref-type="table"}. The mean age was 41.8 ± 21.9 years. There were 46 men (54.8%) and 38 women (45.2%). Most patients presented with an asymptomatic mass (n = 60). Median duration of symptoms was 12 months (range: 1 to 174 months). The histological diagnosis of the tumor was established by biopsy. The samples were obtained in the clinic by making a stab incision and using a small curette to take the tissue for biopsy as recommended by National Comprehensive Cancer Network guidelines. The majority of tumors were located in the lower limb (70.2%). Pleomorphic liposarcoma, synovial cell sarcoma, spindle cell sarcoma and malignant fibrous histiocytoma (MFH) were the most common tumor types, accounting for 65.5% of all tumors. All tumors were STS and were classified according to FNCLCC (tumor differentiation, mitotic activity, and extent of necrosis). Most of the tumors were high grade (84.5%), ≥ 5 cm in size (59.5%) and deep-seated (44%). Eighteen (21.4%), 28 (33.3%), 34 (40.5%) and 4 (4.8%) were categorized as having margin widths of 1 to 4 mm, 5 to 9 mm, 10 to 19 mm and ≥ 20 mm respectively. Postoperative radiation was administered to 60 patients. Patients with prognostic factors indicating high risk for recurrence were recommended for radiation therapy. Radiation therapy was administered for G3 tumors in 27 patients, G2 tumors in 23 patients and G1 tumors in 10 patients. Radiation therapy was given to the entire surgical bed with 3 to 5 cm margin beyond the surgical scar and/or beyond post-operative seroma or areas of ecchymoses. The dose delivered was 50 Gy in 25 fractions using computed tomography (CT) based three dimensional conformal treatment planning. The scar was bolused to ensure full dose to the surface. The field size was then reduced to the primary surgical bed plus a 2 cm margin for a further dose of 10 Gy in 5 fractions. If the margin was microscopically positive a further 6 Gy in 3 fractions was delivered to that area for a total of 66 Gy in 33 fractions.

###### 

Patient characteristics

  **Characteristics**   **Total**    **Margin \<10 mm**   **Margin \>10 mm**   **P value**
  --------------------- ------------ -------------------- -------------------- -------------
  Age                                                                          0.162
  \< 45                 47           23 (50%)             24 (63.2%)            
  ≥ 45                  37           23 (50%)             14 (76.8%)            
  Gender                                                                       0.282
  Male                  46 (54.8%)   27 (58.7%)           19 (50%)              
  Female                38 (45.2%)   19 (41.3%)           19 (50%)              
  Tumor site                                                                   0.350
  Upper                 25 (29.8)    15 (32.6%)           10 (26.3%)            
  Lower                 59 (70.2%)   31 (67.4%)           28 (77.7%)            
  Grade                                                                        0.041
  1                     13 (15.5%)   03 (6.5%)            10 (26.3%)            
  2                     31 (36.9%)   18 (39.1%)           13 (34.2%)            
  3                     40 (47.6%)   25 (54.3%)           15 (39.4%)            
  Size                                                                         0.308
  \<5 cm                34 (40.5%)   17 (37%)             17 (44.7%)            
  \>5 cm                50 (59.5%)   29 (43%)             31 (55.3%)            
  Radio                                                                        0.567
  Yes                   60 (71.4%)   27 (58.7%)           33 (86.8%)            
  No                    24 (28.6%)   19 (41.3%)           11 (13.2%)            
  Margin                                                                        
  1-4 mm                18 (21.4%)   \-                   \-                   \-
  5-9 mm                28 (33.3%)   \-                   \-                   \-
  10-19 mm              34 (40.5%)   \-                   \-                   \-
  \>20                  04 (4.8%)    \-                   \-                   \-
  Depth                                                                        0.111
  Superficial           47 (56%)     29 (63%)             18 (47.4%)            
  Deep                  37 (44%)     17 (37%)             20 (52.6%)            
  Recurrence                                                                   0.112
  Yes                   12 (14.3%)   09 (19.6%)           03 (7.9%)             
  No                    72 (85.7%)   37 (80.4%)           35 (92.1%)            
  Metastasis                                                                   0.303
  Yes                   07 (8.3%)    05 (10.9%)           02 (5.3%)             
  No                    77 (91.7%)   41 (89.1%)           36 (94.7%)            
  Status                                                                       0.006
  Dead                  08 (9.5%)    08 (17.4%)           00 (0%)               
  Alive                 76 (90.5%)   38 (82.6%)           38 (100%)             

Patients' outcome after primary surgery
---------------------------------------

The mean follow-up period (starting from the date of surgery) was 52.6 ± 39.8 months (median 36 months). Twelve patients (14.3%) developed LR at a mean of 7.4 months (median 6 months). Distant metastases occurred in seven patients (8.3%). At the end of the study, 65 patients were alive and without evidence of disease while eight patients died during this period.

Actuarial one year and three year LRFS rates were 87.9% and 85.4%, respectively. There were no local recurrences after three years. The Kaplan--Meier freedom from distant metastases for all patients was estimated to be 95.2% at one year, 94% at two years and 92.8% at three years. There were no distant metastases three years post operatively. Actuarial one year, two year and three year OS rates were 95.2%, 94% and 92.9% respectively.

Prognostic factors influencing survival
---------------------------------------

Table [2](#T2){ref-type="table"} and Table [3](#T3){ref-type="table"} summarize the independent prognostic factors for survival by univariate and multivariate analyses respectively. As expected, higher grade tumor, large size tumor, and margins \< 10 mm were identified as adverse factors associated with worse LRFS, MFS, and OS.

###### 

Survival analysis according to univariate Cox proportional hazard models

  **Characteristics**    **LRFS**   **MFS**         **OS**                                                           
  ---------------------- ---------- --------------- --------- ------ --------------- --------- ------ -------------- ---------
  **Age**                                                                                                             
  \< 45 vs. ≥ 45         1.66       1 to 2.98       0.05      1.27   0.91 to 1.78    0.157     1.02   1.02 to 1.03   0.01
  **Size**                                                                                                            
  \< 5 cm vs. ≥ 5 cm     2.70       1.97 to 3.81    \<0.001   2.47   1.12 to 5.51    0.026     1.74   1.16 to 2.63   0.025
  **Depth**                                                                                                           
  Superficial vs. Deep   1.24       0.78 to 1.95    0.363     1.46   0.82 to 2.6     0.198     1.32   0.92 to 1.88   0.130
  **Grade**                                                                                                           
  Low vs. High           2.1        1.4 to 3.4      \<0.001   3.45   1.63 to 7.373   \<0.001   1.28   1.01 to 1.63   0.04
  **Margin**                                                                                                          
  \< 10 mm vs. ≥ 10 mm   6.344      3.01 to 13.37   \<0.001   3.98   2.2 to 7.11     \<0.001   4.6    2.6 to 8.4     \<0.001

*CHR*, Cox Hazard Ratio; *CI*, confidence interval; *LRFS*, local recurrence-free survival; *MFS*, metastasis-free survival; *OS*, overall survival.

###### 

Survival analysis according to multivariable Cox proportional hazard models

  **Characteristics and Survival endpoints**                   **CHR**   **95% CI**     **P value**
  ------------------------------------------------------------ --------- -------------- -------------
  **Factors associated with local recurrence-free survival**                            
  Size ≥ 5 cm                                                  2.84      2.07 to 3.96   \<0.001
  Grade                                                        2.2       1.1 to 4.5     0.024
  Margin                                                       3.88      1.52 to 9.90   \<0.001
  **Factors associated with metastasis-free survival**                                  
  Grade                                                        2.10      1.33 to 3.30   0.003
  Margin                                                       3.69      1.85 to 7.44   \<0.001
  **Factors associated with overall survival**                                          
  Age                                                          1.02      1.01 to 1.03   0.01
  Margin                                                       2.4       1.2 to 4.5     0.008

*CHR*, Cox Hazard Ratio; *CI*, confidence interval.

Among the 12 patients who had LR, 9 had grade 3 tumors and 10 of the primary tumors were larger than 5 cm. Kaplan Meier curves for patients with a tumor larger than or equal to 5 cm were found to be significantly different from curves for patients with a tumor smaller than 5 cm (*P* \< 0.001). Estimated freedom from local recurrence rates for patients with a tumor larger or equal to 5 cm are 80% versus 94.1%.

Six out of seven patients with distant metastasis had G3 tumors and five had tumors larger than 5 cm. In addition, estimated freedom from distant metastases was significantly longer for patients having G1 and G2 tumors at initial diagnosis than for patients having G3 tumors (*P* \< 0.001). The lungs (62.5%) were the most common site for initial presentation of distant metastasis.

Since margin status was closely associated with local recurrence, the prognostic importance of margin width on LRFS, MFS and OS was estimated by the Kaplan--Meier method. As shown in Figure [1](#F1){ref-type="fig"}, a significant difference was found between groups. Therefore, an adequate negative margin for primary surgery was defined as a margin width ≥ 10 mm.

![**(A) Local recurrence-free survival curves plotted according to 1: margin widths, 2: tumor grade.** (**B**) Distant metastasis-free survival curves plotted according to 1: margin widths, 2: tumor grade. (**C**) Overall survival curves plotted according to 1: margin widths, 2: tumor grade.](1477-7819-10-188-1){#F1}

Discussion
==========

Soft tissue sarcomas are prone to recurrence. Literature has shown that despite apparently complete resections, one-third of patients with extremity STS suffer recurrence, typically within two years of the primary surgery \[[@B6],[@B7]\]. Sarcomas tend to grow along muscle bundles and along fascial septa, sometimes well beyond the boundaries of the palpable tumor mass, and this characteristic at least partly explains the high frequency of local tumor recurrence after limited, or even wide, excision of soft-tissue sarcomas. Two of the most important clinico-pathological features that determine the likelihood of local control are anatomical extent of the sarcoma and whether the tumor was primary or recurrent \[[@B6]\]. It is important for clinicians to be aware that, in many of the more common types of STS (myxoid liposarcoma and myxofibrosarcoma), tumors may advance in grade in any recurrence, thereby increasing the risk of metastasis \[[@B6]\].

Since the development of limb salvage treatment, tumor size, depth, histologic grade, and anatomic site have been well-accepted prognostic factors affecting local recurrence and survival in patients with STS \[[@B8]-[@B10]\].

Pakistan is a third world country and its population is different from others in terms of access to health centers, awareness about the disease and socioeconomic status. There are only a few specialized cancer care centers in the country with a multidisciplinary approach towards these rare STSs. Patients, therefore, end up going to the wrong type of health care personnel and to getting the lesion excised without keeping in mind the suspicion of malignancy and safe margins. By the time they present to the specialized cancer care centers they have a poor prognosis. The presence of a multidisciplinary tumor board is an integral part of multimodal therapy for malignant diseases, particularly for sarcoma \[[@B3]\]. Ours is perhaps the only university hospital in the country which holds a monthly musculoskeletal tumor board meeting. A significant effort is made to evaluate all cases and come to a consensus level of management with regard to multi-modal therapy. Our hospital also maintains a musculoskeletal tumor registry. This registry not only enables our hospital to evaluate its cancer workload and the quality of medical care provided to patients but also serves as a resource for the continuing education of physicians and a stimulus for research by highlighting areas which require further study.

In this study, only those patients were included who came for primary surgery to our institute so that true prognostic factors could be identified. All cases presenting with a previous surgery outside our institute or a recurrence were excluded. We chose this population because no study had been done on them previously. Margin size, tumor grade, tumor-size, tumor depth and age of the patient were included in our study as prognostic factors.

The role of surgical margins has been extensively studied in recent years. Tumor resection for negative margins is the goal of surgical treatment for STSs. The literature has suggested that margin size has a strong correlation with the LRFS and disease specific survival (DSS) \[[@B8]\]. However, most of the studies only defined the margin as either positive (microscopic residual disease) or negative (no residual disease) \[[@B9],[@B13]-[@B16]\]. Liu et al. \[[@B8]\] suggested 10 mm margin width as the critical threshold in identifying 'adequate margin'. In contrast, the individual anatomy of the upper extremities, in particular of the hand, leads to an intentional reduction of resection margins in order to preserve the extremity and its function with the main intention of tumor-free resection margins \[[@B17]\]. On the other hand, authors such as Gronchi et al. \[[@B14]\] failed to confirm the prognostic influence of margin status on DSS in their study. This could be due to a higher number of liposarcomas in their study in which there are higher chances of achieving negative margins \[[@B14]\]. In this study, we found that margin size had a significant influence on LRFS, MFS and OS.

We also found that high grade tumors had higher risks of inadequate margins compared with low grade tumors \[[@B8]\]. This finding was consistent with a study carried out by Liu et al. Tumor depth has also been reported to be associated with local failure as well as poor over all prognosis. However, we failed to confirm the prognostic significance of tumor depth in our study, similar to results reported by Peiper et al. \[[@B18]\].

The significance of advanced age has been highlighted in several studies. Older age has been reported to be associated with lower survival rates in patients with STS \[[@B13],[@B14],[@B19]\]. Older patients tend to present with larger and higher grade tumor which possibly result in increased local recurrences \[[@B20]\]. Treatment variables can also be implicated as potential confounders for the effect of age, with a lower proportion of the elderly having definitive surgery or receiving chemotherapy \[[@B20]\] and radiotherapy \[[@B21]\]. Another study showed that the proportion of positive margins increased progressively with age \[[@B22]\]. All these factors can lead to a poor prognosis for patients more than 45 years old. In this study age had significant effect on overall survival; however we failed to confirm its prognostic influence on LRFS and MFS. Similar findings have been reported by Salo et al. \[[@B23]\] and Atalar et al. \[[@B24]\].

According to recommendations of the National Comprehensive Cancer Network guidelines, RT has been included in the paradigm to maintain excellent local control for high grade tumors although trials have failed to demonstrate a survival benefit. However, for low-grade tumors, observation is recommended unless there are close margins \[[@B25]\]. Schreiber *et al*. \[[@B26]\] tested the impact of postoperative radiation on OS for high-grade STS of the extremities on the Surveillance, Epidemiology and End Results (SEER) database and concluded that the use of postoperative radiation after radical limb sparing excision is associated with an improved OS and DSS only for patients with tumors \>5 cm. In our study, radiotherapy was recommended for patients with tumors exhibiting high risk factors for recurrence. The retrospective nature of this study and the inherent selection bias limit conclusions with regard to the effectiveness of radiotherapy in maintaining local control.

Pre-operative radiotherapy, adjuvant and neo-adjuvant chemotherapy are not included in the standard treatment protocol for STS. These treatment modalities may be used when the tumor is of borderline operability and pre-operative radiotherapy/chemotherapy is judged to be capable of rendering the tumor operable. Adjuvant chemotherapy may be considered in situations where local relapse would be untreatable or where adequate radiotherapy could not be administered owing to the sensitivity of adjacent structures (class 2B evidence). In this study, chemotherapy was not used routinely but on a case by case basis if it was thought useful to spare the limb and often in combination with radiotherapy \[[@B27]\].

This study, however, is limited by the large time span and its retrospective design, which may result in temporal differences in factors such as patient profile, disease characteristics and treatment protocols and follow-up decisions. However in our data, year-wise split did not show such variance.

Conclusions
===========

We conclude that tumor size, tumor grade and margin status had a prognostic influence in our patients. Despite the lack of facilities and few multidisciplinary cancer care centers for these rare sarcomas, our results were no different from the data published from the developed world.
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